of
Author:
Publisher
Springer US
Link
https://link.springer.com/content/pdf/10.1007/978-1-0716-1450-1_11
Reference29 articles.
1. Duggan JX, Vazvaei F, Jenkins R (2015) Bioanalytical method validation considerations for LC-MS/MS assays of therapeutic proteins. Bioanalysis 7(11):1389–1395
2. Vande Casteele N, Herfarth H, Katz J, Falck-Ytter Y, Singh S (2017) American Gastroenterological Association Institute technical review on the role of therapeutic drug monitoring in the management of inflammatory bowel diseases. Gastroenterology 153(3):835–857. e836
3. Iwamoto N, Shimada T (2019) Regulated LC-MS/MS bioanalysis technology for therapeutic antibodies and fc-fusion proteins using structure-indicated approach. Drug Metab Pharmacokinet 34(1):19–24
4. Iwamoto N, Shimada T (2018) Recent advances in mass spectrometry-based approaches for proteomics and biologics: great contribution for developing therapeutic antibodies. Pharmacol Ther 185:147–154
5. Li H, Ortiz R, Tran L et al (2012) General LC-MS/MS method approach to quantify therapeutic monoclonal antibodies using a common whole antibody internal standard with application to preclinical studies. Anal Chem 84(3):1267–1273
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. 8 Universal LCMS-based assay platform, refmAb-Q nSMOL, for monitoring monoclonal antibody therapeutics using one reference antibody;Regular and Young Investigator Award Abstracts;2022-11
2. g-C3N4@TiO2@Fe3O4 Multifunctional Nanomaterial for Magnetic Solid-Phase Extraction and Photocatalytic Degradation-Based Removal of Trimethoprim and Isoniazid;ACS Omega;2022-06-27
3. A rapid and universal liquid chromatograph-mass spectrometry-based platform, refmAb-Q nSMOL, for monitoring monoclonal antibody therapeutics;2022-04-23
4. A rapid and universal liquid chromatograph-mass spectrometry-based platform, refmAb-Q nSMOL, for monitoring monoclonal antibody therapeutics;The Analyst;2022
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3